ARC Mini-Symposium: Etiology and treatment of Type 1 Diabetes

Coffee and light breakfast at 8:30 am Session 1 Chair: Barbara Corkey, PhD 9:00 – 9:50 Keynote Talk Matthias von Herrath, MD, Novo Nordisk Type 1 Diabetes R&D Center and La Jolla Institute for Allergy and Immunology, Type 1 Diabetes Center New surprises from analyzing the histopathology of human Type 1 Diabetes - implications for treatment design? 9:50 – 10:15 Devin Steenkamp, MD, Boston Medical Center, Section of Endocrinology, Diabetes Services Type 1 Diabetes: A clinician’s perspective 10:15 – 10:40 Hans Dooms, PhD, Boston University School of Medicine, Department of Medicine, Arthritis Center/Rheumatology Section Targeting the IL-7 pathway in Type 1 Diabetes 10:40 – 10:55 Coffee break Session 2 Chair: Barbara Nikolajczyk, PhD 10:55 – 11:45 Keynote Talk Li Wen, MD, PhD, Yale University School of Medicine, Department of Internal Medicine, Section of Endocrinology Innate immunity and gut microbiome in diabetes 11:45 – 12:10 Doug Lauffenburger, PhD, Massachusetts Institute of Technology, Department of Biological Engineering In Vivo Systems Analysis of Inflammatory Pathologies 12:10 - 12:35 Barbara Corkey, PhD, Boston University School of Medicine, Department of Medicine, Obesity Research Center Metabolic and Signaling Differences between T1D and Control Human Fibroblasts 12:35 – 2:00 Lunch and round table discussion